In a review of 52 infants with hemolytic disease (33 Rh incompatibility, 19 ABO incompatibility) and comorbid factors, approximately 95% of whom developed kernicterus, the peak total serum bilirubin in both groups was approximately 32 mg/dL , with an approximate range of 18 to 51 mg/dL
BPC-157: Discovery and Regulatory History BPC-157 is a synthetic pentadecapeptide whose documented history begins with Croatian gastric-physiology research in the early 1990s and extends, through a Pliva-sponsored clinical program and a large preclinical literature, to the anti-doping monitoring status it holds today
We demonstrate that L2HGDH is frequently suppressed in liver tumors, leading to pathological accumulation of its substrate L-2-hydroxyglutarate (L2HG)
Indicated Cases This formulation is most appropriate for: Kittens and small adult cats under 2.5 kg with FIP and confirmed or suspected anaemia Neurological FIP presentations in the small cat weight range Cats presenting with significant appetite loss or weight decline at diagnosis Cases where the owner or attending veterinarian wishes to consolidate antiviral and nutritional support into a single daily injection Cats with a history of B12-responsive conditions alongside a new FIP diagnosis This Formulation Is Not the First Choice For Cats requiring therapeutic-dose B12 supplementation independently maintain a separate B12 protocol as directed Cats over 2.5 kg consider the 30mg/ml + B12 or 40mg/ml + B12 formulations Cases where the veterinarian has specifically indicated the non-B12 formulation Concentration Selection Guide Administration Administer subcutaneously once daily
TB-500 excels at muscle and tendon repair
